STAT+: Definium’s LSD therapy eased anxiety in second large trial

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Definium’s LSD therapy eased anxiety in second large trialWorldPing
Image via STAT.

What happened

The first wave of biotechs is nearing regulatory approval for psychedelic therapies, a class of treatments that appear to exert rapid benefits.

Key facts

  • The first wave of biotechs is nearing regulatory approval for psychedelic therapies, a class of treatments that appear to exert rapid benefits.
  • Reported by STAT and published Mon, 14 Sep 2026 11:00:00 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Related WorldPing coverage

Retrial over 2018 France terror attack beginsWorldPing
France 24

Retrial over 2018 France terror attack begins

The retrial of three defendants linked to a 2018 terror attack in a supermarket in southern France that left four people dead begins in Paris on Monday. The defendants include the former partner of the attacker himself, who was shot dead by the authorities.

Brief by WorldPing · Original reporting by France 24